El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 

Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine?

dc.contributor.authorLuna, Omar F.
dc.contributor.authorGomez, Johana
dc.contributor.authorCardenas, Constanza
dc.contributor.authorAlbericio Palomera, Fernando
dc.contributor.authorMarshall, Sergio H.
dc.contributor.authorGuzmán, Fanny
dc.date.accessioned2020-03-02T17:14:21Z
dc.date.available2020-03-02T17:14:21Z
dc.date.issued2016-11-15
dc.date.updated2020-03-02T17:14:22Z
dc.description.abstractThe deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be affected by side reactions and by-product formation. Several aspects have to be taken into consideration when selecting a deprotection reagent: its physicochemical behavior, basicity (pKa) and polarity, concentration, and time of reaction, toxicity and disposability of residues and, finally, availability of reagents. This report presents a comparison of the performance of three strategies for deprotection using microwave-assisted Fmoc peptide synthesis. Four peptide sequences were synthesized using Rink amide resin with a Liberty Blue automated synthesizer and 4-methylpiperidine (4MP), piperidine (PP), and piperazine (PZ) as Fmoc removal reagents. In the first instance all three reagents behaved similarly. A detailed analysis showed a correlation between the hydrophobicity and size of the peptide with the yield and purity of the obtained product. The three reagents are interchangeable, and replacement of piperidine could be advantageous regarding toxicity and reagent handling.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec681055
dc.identifier.issn1420-3049
dc.identifier.pmid27854291
dc.identifier.urihttps://hdl.handle.net/2445/151704
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules21111542
dc.relation.ispartofMolecules, 2016, vol. 21, num. 11, p. 1542
dc.relation.urihttps://doi.org/10.3390/molecules21111542
dc.rightscc-by (c) Luna, Omar F. et al., 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)
dc.subject.classificationSíntesi de pèptids
dc.subject.classificationAmines
dc.subject.otherPeptide synthesis
dc.subject.otherAmines
dc.titleDeprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine?
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
681055.pdf
Mida:
2.51 MB
Format:
Adobe Portable Document Format